| Product NDC: | 51879-170 |
| Proprietary Name: | StaphAseptic |
| Non Proprietary Name: | benzethonium chloride, lidocaine hydrochloride |
| Active Ingredient(s): | 2; 25 mg/g; mg/g & nbsp; benzethonium chloride, lidocaine hydrochloride |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51879-170 |
| Labeler Name: | Tec Laboratories, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part348 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20060522 |
| Package NDC: | 51879-170-02 |
| Package Description: | 1 TUBE in 1 CARTON (51879-170-02) > 56.7 g in 1 TUBE |
| NDC Code | 51879-170-02 |
| Proprietary Name | StaphAseptic |
| Package Description | 1 TUBE in 1 CARTON (51879-170-02) > 56.7 g in 1 TUBE |
| Product NDC | 51879-170 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | benzethonium chloride, lidocaine hydrochloride |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20060522 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Tec Laboratories, Inc. |
| Substance Name | BENZETHONIUM CHLORIDE; LIDOCAINE HYDROCHLORIDE |
| Strength Number | 2; 25 |
| Strength Unit | mg/g; mg/g |
| Pharmaceutical Classes |